Clinical Trials

Infliximab in ankylosing spondylitis: The ASSERT (Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy) & IMPACT II (Infliximab Multinational Psoriatic Arthritis Controlled Trials)

The effect of infliximab on inflammation and bone formation biomarkers and associations with clinical response in ankylosing spondylitis and psoriatic arthritis

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here